Metro Healthcare Indonesia Tbk. vs Sinergi Multi Lestarindo Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp428 (market cap 14.23T, 346.3K 24h volume), while Sinergi Multi Lestarindo Tbk. trades at Rp128 (market cap 302.66B, 13.94M 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 47× Sinergi Multi Lestarindo Tbk.'s market cap, and Sinergi Multi Lestarindo Tbk. is more actively traded (13.94M versus 346.3K). Which is the better fit depends on your goals.
| CARE | SMLE | |
|---|---|---|
Market Cap | 14.23T | 302.66B |
Volume | 346.3K | 13.94M |
Lot | 3.46K | 139.35K |
Turnover | 147.93M | 1.79B |
Average Price | 427.18 | 128.36 |
Value | 147.93M | 1.79B |
Indicative Equilibrium Price | 428 | 128 |
Indicative Equilibrium Volume | 10 | 17 |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.
Read more on SMLE →